Telomere shortening is associated with depression and cognitive impairment in adults

Published Date: 02 Mar 2023

A new research paper titled "The Relationship Between Telomere Shortening in Older Adults and Early Depressive Symptoms and Cognitive Impairment" has been published in Aging.

Read Full News

Latest News

The Flawed V02 Max Craze

Eric Topol explains the difference between cardiorespiratory fitness and maximal oxygen uptake.

New Adjuvant Option in Node-Positive ER+ Breast Cancer

Dr Kathy Miller evaluates the lidERA trial, comparing adjuvant giredestrant vs standard therapy in node-positive ER+ breast cancer.

Fluticasone-Vilanterol in COPD: Fewer Puffs, Slight Benefit

The use of fluticasone furoate-vilanterol inhalers is tied to slightly better clinical outcomes than the use of budesonide-formoterol or fluticasone propionate-salmeterol inhalers in new COPD users.

Prediabetes Detection: A Critical Lever for Health Systems

Dr Aman Chawla explains why prediabetes detection is a strategic lever for health systems aiming to improve quality and lower total cost of care.

GLP-1 Therapy: Cancer Benefit or Bias?

Dr Maurie Markman examines new data on GLP-1 agonists and cancer risk, which shows promising reductions in several cancers but concerning kidney signals.

The Trade-Offs Behind Life as a GP Locum

Flexibility and autonomy attract many GPs to locum work, but financial volatility and limited career progression complicate the picture.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Todays Updates

Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer

In a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.

FDA OKs Upfront Nivolumab+Chemo for Classic Hodgkin Lymphoma

The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.

Latest News

Eric Topol explains the difference between cardiorespiratory fitness and maximal oxygen uptake.

Dr Kathy Miller evaluates the lidERA trial, comparing adjuvant giredestrant vs standard therapy in node-positive ER+ breast cancer.

The use of fluticasone furoate-vilanterol inhalers is tied to slightly better clinical outcomes than the use of budesonide-formoterol or fluticasone propionate-salmeterol inhalers in new COPD users.

Dr Aman Chawla explains why prediabetes detection is a strategic lever for health systems aiming to improve quality and lower total cost of care.

Dr Maurie Markman examines new data on GLP-1 agonists and cancer risk, which shows promising reductions in several cancers but concerning kidney signals.

Flexibility and autonomy attract many GPs to locum work, but financial volatility and limited career progression complicate the picture.

News All Time

Wheelchair Evolution: From Handbikes to Electric Drives

Invented by users and refined by engineers, wheelchairs now span €200 hospital loans to €30,000 custom models — a spectrum that raises clinical, economic and ethical questions.

Vitamin D Unlikely to Improve IBD Disease Activity

Patients with IBD may experience increased serum levels of vitamin D with supplementation, but improvement in disease activity or inflammation remains uncertain.

Study Finds 1 in 3 Patients With IBD Develop Anemia

A global meta-analysis finds that anemia affects 37% of patients with inflammatory bowel disease, highlighting gaps in monitoring and treatment.

Social Media Use Tied to Emotional Issues

The use of digital media, particularly social media, in 2- to 19-year-olds is linked to poor outcomes, including increased depression and lower academic achievement, according to a meta-analysis.

Not Much Gain From Starting TNF Inhibitors Early in axSpA

Starting a TNF inhibitor within 1 year of the onset of back pain may not improve clinical outcomes or drug retention compared with starting therapy after axial spondyloarthritis is established.

Children With Autism Face Multitude of Comorbidities: Study

They also face more disadvantages in multiple social determinants of health such as poverty, food hardship, and lead exposure.

Genomics and AI Will Up Precision of Glaucoma Care

Polygenic risk scores in development for glaucoma could usher in more personalized estimates of risk.

Doctors Argue ‘Provider’ Blurs Clinical Roles

The American College of Physicians says the term ‘provider’ blurs lines between nurse practitioners and physicians, confuses patients, and fails to recognize expertise.

Can Biomarkers Distinguish Psychosis From Depression?

A large international study reports no overlap between the biological signatures of early depression and psychosis.

New Telehealth Standards: The Upshot for Australian Doctors

A consortium of telehealth companies and insurers has published its ‘National Telehealth Standards,’ but some question the document’s impact.

Exercise Frequency, Cadence May Predict White Matter Health

The frequency of physical activity and step cadence may be the top predictors of brain health outcomes in adults aged 40 years or older, new research suggests.

Early Treatment Goes a Long Way for Ulcerative Colitis

In patients with ulcerative colitis, initiation of biologic therapy within 12 months of diagnosis is linked to a lower risk for disease progression than later initiation.

'Concerning': CRC Continues to Shift Toward Younger Adults

Nearly half of new colorectal cancer cases now occur in people younger than age 65 years, highlighting the need for earlier screening and better symptom awareness.

2026-2027 Flu Vaccine Recommendation Covers Subclade K

The agency’s advisors express concern about low vaccine uptake and this season’s mismatched strains.

First-Trimester Oropouche Linked to Brain Malformations

The study ties first-trimester Oropouche infection to severe fetal neurodevelopmental anomalies and urges RT-PCR within 2-7 days plus multiplex arbovirus testing to rule out co-infection.

Side Gigs: Earning Extra Income From Chart Review

Reviewing workers’ compensation charts for insurers can be a lucrative side gig for physicians. Here’s what you should know.

Recommended News For You

Advanced imaging, targeted therapy help men with prostate cancer safely defer surgery and radiation therapy

A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.

Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

Doctors say lung cancer is still the deadliest cancer, but hope is growing

According to the CAPTIVATE Study, fixed-duration ibrutinib plus venetoclax may be beneficial for patients with high-risk chronic lymphocytic leukemia.

Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke

Recommended Articles For You

The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025 

Treating Methemoglobinemia: What You Need to Know Now! 

The Future is Now: Navigating the Precision Revolution in Oncology Treatment 

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants

2.

Cardiopulmonary fitness is key for helping breast cancer patients manage post-diagnosis symptoms, say researchers

3.

Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts

4.

When does a melanoma metastasize? Implications for management

5.

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

1.

Understanding SVR Normal Range: A Guide to Achieving Optimal Health

2.

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late

3.

The Mystery of Carotid Body Tumors: The Facts You Need to Know

4.

Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology

5.

Everything You Need to Know About RDW-CV: A Comprehensive Guide 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

2.

Cost Burden/ Burden of Hospitalization For R/R ALL Patients

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III

5.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot